These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24755440)

  • 1. Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease.
    Steinberg BA; Broderick SH; Lopes RD; Shaw LK; Thomas KL; DeWald TA; Daubert JP; Peterson ED; Granger CB; Piccini JP
    Europace; 2014 Sep; 16(9):1284-90. PubMed ID: 24755440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease.
    Piccini JP; Al-Khatib SM; Wojdyla DM; Shaw LK; Horton JR; Lokhnygina Y; Anstrom KJ; DeWald T; Allen-LaPointe N; Steinberg BA; Thomas K; Daubert JP; Peterson ED
    Am J Cardiol; 2014 Sep; 114(5):716-22. PubMed ID: 25129065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial.
    Steinberg BA; Hellkamp AS; Lokhnygina Y; Halperin JL; Breithardt G; Passman R; Hankey GJ; Patel MR; Becker RC; Singer DE; Hacke W; Berkowitz SD; Nessel CC; Mahaffey KW; Fox KA; Califf RM; Piccini JP;
    Heart Rhythm; 2014 Jun; 11(6):925-32. PubMed ID: 24833235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    Kipp R; Askari M; Fan J; Field ME; Turakhia MP
    JACC Clin Electrophysiol; 2019 Feb; 5(2):231-241. PubMed ID: 30784696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.
    Saksena S; Slee A; Waldo AL; Freemantle N; Reynolds M; Rosenberg Y; Rathod S; Grant S; Thomas E; Wyse DG
    J Am Coll Cardiol; 2011 Nov; 58(19):1975-85. PubMed ID: 22032709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery disease.
    Pantlin PG; Bober RM; Bernard ML; Khatib S; Polin GM; Rogers PA; Morin DP
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):607-611. PubMed ID: 31912933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between the Use of Antiarrhythmic Drugs in Non-Valvular Atrial Fibrillation and Patient Prognosis Using Data from the China Atrial Fibrillation (China-AF) Registry.
    Hou XX; Du X; Zheng D; Li YM; He L; Li XX; Dong JZ
    Med Sci Monit; 2019 Jun; 25():4856-4868. PubMed ID: 31256190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs.
    Allen LaPointe NM; Dai D; Thomas L; Piccini JP; Peterson ED; Al-Khatib SM
    Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):292-300. PubMed ID: 25829248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines-Atrial Fibrillation Registry.
    Field ME; Holmes DN; Page RL; Fonarow GC; Matsouaka RA; Turakhia MP; Lewis WR; Piccini JP;
    Circ Arrhythm Electrophysiol; 2021 Feb; 14(2):e008961. PubMed ID: 33419385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current status of the clinical practice and analysis on the ratioanl prescription of antiarrhythmic drugs in Chinese patients with atrial fibrillation: Results from the Chinese Atrial Fibrillation Registry (CAFR) trial].
    Sun LJ; Du X; Liu SW; He R; Zeng H; Sun C; Li L; Zhang Y; Ma CS; Gao W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):740-747. PubMed ID: 32957756
    [No Abstract]   [Full Text] [Related]  

  • 11. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.
    Allen LaPointe NM; Dai D; Thomas L; Piccini JP; Peterson ED; Al-Khatib SM
    Am J Cardiol; 2015 Feb; 115(3):316-22. PubMed ID: 25491240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study.
    Andersen SS; Hansen ML; Gislason GH; Schramm TK; Folke F; Fosbøl E; Abildstrøm SZ; Madsen M; Køber L; Torp-Pedersen C
    Europace; 2009 Jul; 11(7):886-91. PubMed ID: 19443433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
    Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Adelstein E; Jain SK; Saba S
    J Cardiol; 2016 May; 67(5):471-6. PubMed ID: 26233885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs.
    Friberg L
    Am Heart J; 2018 Nov; 205():118-127. PubMed ID: 30236980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
    Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM
    Card Electrophysiol Rev; 2003 Sep; 7(3):201-7. PubMed ID: 14739713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited duration of antiarrhythmic drug use for newly diagnosed atrial fibrillation in a nationwide population under age 65.
    D'Angelo RN; Rahman M; Khanna R; Yeh RW; Goldstein L; Yadalam S; Kalsekar I; Tung P; Zimetbaum PJ
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1529-1537. PubMed ID: 33760297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Antiarrhythmic Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation (EAST-AF) trial.
    Kaitani K; Inoue K; Kobori A; Nakazawa Y; Ozawa T; Kurotobi T; Morishima I; Miura F; Watanabe T; Masuda M; Naito M; Fujimoto H; Nishida T; Furukawa Y; Shirayama T; Tanaka M; Okajima K; Yao T; Egami Y; Satomi K; Noda T; Miyamoto K; Haruna T; Kawaji T; Yoshizawa T; Toyota T; Yahata M; Nakai K; Sugiyama H; Higashi Y; Ito M; Horie M; Kusano KF; Shimizu W; Kamakura S; Morimoto T; Kimura T; Shizuta S;
    Eur Heart J; 2016 Feb; 37(7):610-8. PubMed ID: 26417061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease.
    Burnham TS; May HT; Bair TL; Anderson JA; Crandall BG; Cutler MJ; Day JD; Freedman RA; Knowlton KU; Muhlestein JB; Navaravong L; Ranjan RA; Steinberg BA; Bunch TJ
    Am Heart J; 2022 Jan; 243():127-139. PubMed ID: 34537183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.
    Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM;
    Heart; 2002 Oct; 88(4):357-62. PubMed ID: 12231591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.